Mouth ulcers or sores are small lesions that mostly appear inside the mouth and are painful when eating, drinking or brushing. Mouth ulcers are not contagious and mostly heal within three weeks of the onset. A doctor’s advice is necessary if these last over three weeks. It has been observed that around 2% to 60% of the global population is suffering from various types of mouth ulcers. The global mouth ulcer treatment market is experiencing significant growth due to high prevalence rate and low cost of treatment procedures. Moreover, easy availability of the products for the treatment of mouth ulcers is one of the major factors supporting the growth of the market. However, steroid mouthwash cannot be used by children due to significant side effects and high failure rate of the clinical trial pipeline analysis of mouth ulcer products. This would hamper the growth of the market. The global mouth ulcers treatment market was valued at USD 1,242.6 million in 2013 and is expected to reach an estimated value of USD 1,596.9 million in 2020, growing at a CAGR of 3.8% from 2014 to 2020.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/977
Based on formulation, the mouth ulcers treatment market is segmented as mouthwash, gels, sprays and lozenges. In 2013, gels segment contributed the largest market share of the global market owing to easy availability in all leading medical stores coupled with rising preference by healthcare professionals. Likewise, lozenges formulation segment is expected to grow at the highest growth rate during the forecast period from 2014 to 2020. This growth was mainly attributed to increasing number of companies entering into development and manufacturing of lozenges. For instance, Combe Incorporated manufactures Cepacol Fizzlers, which is anesthetic in nature. Similarly, Blistex Inc. has also entered into the production of lozenges under the brand name Kank-a.
Inquiry on this report @ http://www.mrrse.com/enquiry/977
Aphthous stomatitis indication segment accounted for the largest market share of the global mouth ulcers treatment market and is expected to grow at a highest rate during the forecast period from 2014 to 2020. Factors such as high prevalence rate and easily availability of treatment product are supporting the growth of this market segment. The International Journal of Health and Nutrition published in 2013 that the prevalence of aphthous stomatitis ranged from 2% to 60% among the global population. Likewise, corticosteroid is the first line of treatment for mouth ulcers. Hence, it contributed the largest market share in 2013 and is expected to grow at a highest CAGR from 2014 to 2020. Dominance of this market segment is mostly attributed to faster healing, highly effective treatment, quick recovery from the ulcer pain and available in all formulations such as mouthwash, gels, sprays and lozenges.
Geographically, North America was the largest market for mouth ulcers treatment in 2013 and is anticipated to maintain its dominance by the end of 2020. Dominance of North American region in this market was witnessed due to increasing awareness among people about mouth ulcers, high prevalence rate of mouth ulcers and rising demand for mouth ulcers treatment. Europe accounted for the second largest share in the global mouth ulcers treatment market. Geriatric are the potential population primarily driving the mouth ulcers treatment market in Europe.
Read Complete Report with TOC @ http://www.mrrse.com/mouth-ulcers-treatment
Asia-Pacific is expected to grow at the highest CAGR from 2014 to 2020. This growth was mainly attributed to rising incidences of mouth ulcers coupled with favorable government initiatives are expected to boost the market for mouth ulcers treatment. For instance, Annals of Clinical Psychiatry in 2013 stated, around 51.0% people were diagnosed with recurrent aphthous stomatitis in Asia. Lozenge segment is the most lucrative segment in the region owing to easy availability and low cost of the product. Likewise, gel formulation accounted for the largest market share in 2013, as most of the doctors and pharmacists preferred gel as a first line treatment for mouth ulcers in Asian countries. Major players operating in this market include 3M Healthcare, Bristol Meyer Squibb Company, ECR Pharmaceuticals, GlaxoSmithKline plc and Church & Dwight Co, Inc.
90 State Street,
Albany NY – 12207